(Q42991707)

12 November 2017

title

Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A. (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

Eike Steinmann

2

0 references

Ralf Bartenschlager

object named as

Ralf Bartenschlager

8

0 references

Sandra Ciesek

1

object named as

Sandra Ciesek

1 reference

12 November 2017

4

Michael P Manns

1 reference

12 November 2017

3

Heiner Wedemeyer

1 reference

12 November 2017

9

Thomas von Hahn

1 reference

12 November 2017

Johann Neyts

5

1 reference

12 November 2017

Norbert Tautz

6

1 reference

12 November 2017

Vanesa Madan

7

1 reference

12 November 2017

Thomas Pietschmann

10

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

12 November 2017

1 reference

12 November 2017

volume

50

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

1638-1645

1 reference

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

12 November 2017

cites work

1 reference

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3

21 January 2018

1 reference

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

21 January 2018

1 reference

Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture

21 January 2018

1 reference

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

21 January 2018

1 reference

Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo

21 January 2018

1 reference

NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon

21 January 2018

1 reference

The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

21 January 2018

1 reference

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro

21 January 2018

1 reference

Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase

21 January 2018

1 reference

Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro

21 January 2018

1 reference

Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions

21 January 2018

1 reference

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

21 January 2018

1 reference

Human and Escherichia coli cyclophilins: sensitivity to inhibition by the immunosuppressant cyclosporin A correlates with a specific tryptophan residue.

21 January 2018

1 reference

The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro

21 January 2018

1 reference

Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B.

21 January 2018

1 reference

Structure of the catalytic domain of the hepatitis C virus NS2-3 protease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.23281

1 reference

12 November 2017

1 reference